Back to search

Alliance Pharmaceuticals Limited

6 contracts won£1,537,495,000 total value

Every public sector contract Alliance Pharmaceuticals Limited has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows Alliance Pharmaceuticals Limited for you, and alerts you the moment a renewal goes live.

Where they win

The sectors, tender types and buyers where Alliance Pharmaceuticals Limited wins most often.

See every live NHS tenders and find your next contract before they do.

See all NHS buyers and UK contract awards.

Sectors

Healthcare & Medical6

Top Buyers

NHS England
3 contracts
£1,535,500,000
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
1 contract
£710,000
The NHS Commissioning Board (operating under the name of NHS England)
1 contract
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
1 contract
£1,285,000

Awards(6)

Sort:

Stoma Acute Patient

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Edinburgh
£710,000
Awarded 7 Feb 2025

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS England
Runcorn
£1,009,500,000
Awarded 5 Apr 2024
Ends 30 Apr 2028

NHS Framework Agreement for Branded Medicines - National Tender

NHS England
Leeds
Not specified
Awarded 16 May 2022

NHS Framework Agreement for Branded medicines - National

NHS England
Runcorn
£526,000,000
Awarded 16 May 2022
Ends 30 Apr 2024

NHS National Generic Pharmaceuticals Wave 13

The NHS Commissioning Board (operating under the name of NHS England)
Runcorn
Not specified
Awarded 30 Dec 2021

Contract for the Supply of Chloroquine Tablets

The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
UK
£1,285,000
Awarded 8 Apr 2020

Know when Alliance Pharmaceuticals Limited's contracts come up for renewal

Business predicts when each of these contracts is due to be re-tendered, follows Alliance Pharmaceuticals Limited for you, and alerts you the moment a renewal goes live, so you can bid before the incumbent locks it in again.

Why track Alliance Pharmaceuticals Limited?

Alliance Pharmaceuticals Limited is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.

How renewal tracking works

We aggregate Alliance Pharmaceuticals Limited's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.

What you can do here

  • Review the full history. Every contract Alliance Pharmaceuticals Limited has won, with the buyer, value and dates for each.
  • Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
  • Track and get alerted. Follow Alliance Pharmaceuticals Limited and be notified when their contracts come up again (Business).
  • Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.

Frequently asked questions

Where does this data come from?

Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.

Is the contract history free?

Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.

How do you predict renewals?

From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.